Qiagen NV | QIA - Current Liabilities


Qiagen NV reported $512.14M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Akebia Therapeutics USD 173.88M 10.95M Mar/2026
Alaunos Therapeutics USD 595K 218K Mar/2026
argenx SE USD 1.32B 278.28M Dec/2025
Avita Medical AUD 62.68M 77K Dec/2025
Dianthus Therapeutics USD 38.28M 7.55M Mar/2026
Ionis Pharmaceuticals USD 717M 66M Mar/2026
IQVIA Holdings USD 8.33B 9M Mar/2026
Moderna USD 2.4B 408M Mar/2026
Organon & Co USD 2.5B 110M Mar/2026
Qiagen NV USD 512.14M 461.26M Dec/2025
Revvity USD 1.24B 92.6M Mar/2026
Tectonic Therapeutic USD 12.96M 3.29M Mar/2026
Viatris USD 6.81B 284M Mar/2026
Xeris Pharmaceuticals USD 118.59M 9.02M Mar/2026